Perceptions of The Health Risks of Cosmetics, and What it means to Their Regulation

Instructor: Rob Ross Fichtner
Product ID: 704955
  • Duration: 90 Min
This webinar will discuss some of the major issues in the regulation of cosmetics. Upon completion of the session attendees will learn how regulators regulate cosmetics compared to other categories, fine line between cosmetics and drugs, and future directions for cosmetic regulations.

recorded version

1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section
Last Recorded Date: Jan-2017

Training CD / USB Drive

One CD/USB is for usage in one location only.
(For multiple locations contact Customer Care)
CD/USB and Ref. material will be shipped within 15 business days

Customer Care

Fax: +1-650-362-2367

Email: [email protected]

Read Frequently Asked Questions

Why Should You Attend:

Nowhere in the world today do we have a united assessment of the risk proposed by cosmetics. There are often completely opposing views from consumers, scientists, NGOs, regulators and the companies who develop and market these products. Cosmetic labels scream of all of the nasty chemicals they do not contain. But who says they are nasty? Where’s the proof?

Furthermore, the regulation of cosmetics is often thought as “regulation light”, and a subject not taken seriously. Cosmetic regulations today are complex and becoming more so. Even more importantly, cosmetic science is spectacularly advanced and now borders on drug and medical device science.

Exacerbating the situation is that there is no harmonized global approach to regulation. Drugs and medical devices have, by comparison, far more consistent approaches, and receive a great deal of assistance from regulators in granting approvals. In many global markets, cosmetics simply arrive on store shelves and often the first intersection with a regulator is with a warning capable of threatening a company’s business.

This webinar will speak to some of the major issues in the science and regulation of cosmetics. While the focus will be on North America, there will be a general discussion on what regulatory framework this category deserves. What are the challenges facing the industry and regulators? Where is the line between cosmetics and drugs? How do we deal with the exciting and challenging innovations such as cosmetic active ingredients, medical devices and nutritional supplements for beauty? And finally, just how risky are today’s cosmetic products?

Learning Objectives:

From the seminar you will learn:

  • The competing views of cosmetic risk
  • How regulators regulate cosmetics compared to other categories
  • The key issues regulating cosmetics
  • The very fine line between cosmetics and drugs
  • The roles of organizations influencing cosmetic regulations
  • Future directions for cosmetic regulations

Areas Covered in the Webinar:

  • Competing views of the risk of cosmetics
  • Current approaches to the regulation of Cosmetics
  • Issues with Cosmetic Regulation
  • Organizations influencing regulations: governments, industry, NGOs
  • Future predictions for Cosmetic Regulation
  • How much risk do cosmetics pose?

Who Will Benefit:

  • Regulatory affairs
  • Research and Development
  • Marketing personnel
  • Manufacturers
  • Brand owners
  • Importers and Distributors
Instructor Profile:
Rob Ross Fichtner

Rob Ross Fichtner
President and CEO, Focal Point Research Inc

Rob Ross-Fichtner (President & CEO Focal Point Research Inc., Professor at Seneca College) has more than 35 years of experience in the formulation, manufacturing and regulation of cosmetics, drugs, medical devices and nutritional supplements. He has completed hundreds of regulatory submissions for product registration and approval, and has served as a consultant to companies of all sizes around the world pertaining to their Canadian and US compliance. He has also served as a consultant directly to Health Canada.

Rob has extensive experience inspecting Cosmetic and OTC drug facilities and developing QA programs in Canada, the US and in international locations. He also has many years of experience in Research and Development, including formulation, stability and analytical chemistry, clinical trials and manufacturing. He has served as an expert witness in litigation, and contributes regularly to the development of intellectual property.

Follow us :
Seminars by Ex-FDA Officials
Ensuring Compliance with Advertising and Promotional Requirements for Drugs and Medical Devices

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.

We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email [email protected] call +1-888-717-2436 (Toll Free).

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed